Bolt Biotherapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,804 | $1,222 | $24,092 | $1,141 |
Gross Profit | 1,804 | 1,222 | 8,201 | 1,141 |
EBITDA | -8,863 | -11,716 | -15,510 | -16,003 |
EBIT | -9,210 | -12,115 | -15,936 | -16,443 |
Net Income | -8,561 | -11,040 | -15,936 | -15,176 |
Net Change In Cash | 1,804 | 1,222 | 24,092 | 1,141 |
Free Cash Flow | -9,597 | -13,365 | -14,430 | -14,007 |
Cash | 9,601 | 8,391 | 7,205 | 9,366 |
Basic Shares | 1,917 | 38,339 | 38,285 | 38,250 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $7,690 | $7,876 | $5,729 | $1,260 |
Gross Profit | 5,509 | 5,992 | 838 | -2,412 |
EBITDA | -66,455 | -74,342 | -88,655 | -91,595 |
EBIT | -68,236 | -76,196 | -93,546 | -95,267 |
Net Income | -63,118 | -69,197 | -85,875 | -104,394 |
Net Change In Cash | 7,690 | 7,876 | 5,729 | 1,260 |
Free Cash Flow | -61,330 | -69,731 | -78,457 | -59,404 |
Cash | 7,205 | 10,810 | 9,244 | 27,383 |
Basic Shares | 38,183 | 37,811 | 37,358 | 37,399 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$4.46 |
2025-03-31 | -$0.29 |
2024-12-31 | -$0.42 |
2024-09-30 | -$0.40 |
